Market Report on Biologics Industry announces a report on “Market Report on Biologics Industry”. The report serves as a guide to Biologics industry, covering more than 1000 companies that are engaged in Biologics products and services.

This report on Biologics gives a market insight into products types including Monoclonal Antibodies, Blood & Blood Products, Vaccines, Insulin and Other, for both human and animal consumption. Market projections and estimates are illustrated by region and by type. The report serves as a guide to Biologics industry, covering more than 1000 companies that are engaged in Biologics products and services. Major Contract Research Organizations, Research Institutes and Universities serving the Animal Biologics industry are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to Biologic products is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, and Rest of World with 165 exclusive graphically represented exhibits.

Global Biologics Value Market is projected to grow about 9% compounded annually from 2010 through 2022. North America is projected to occupy about 50% of the total global market. Blood and blood products are the major product area with tremendous potential and growth. Automated blood collection and processing systems as well as prior-screening capabilities of latest assays are expected to enhance quantity and quality of blood. Since the last decade, the therapeutic market for monoclonal antibodies has grown exponentially. Bevacizumab, trastuzumab, adalimumab, infliximab and rituximab are the top five therapeutic antibodies available. About 40% of the best selling biopharmaceuticals are therapeutic monoclonal antibodies. Development of vaccines has proved be crucial and effective in the pharmaceutical industry. Growing human and animal populations and advancement of science and technology are the driving factors behind the global vaccines market. High prevalence of diabetes, treatment and diagnosis rates, device penetration and changes in price are driving the human insulin market. AS per WHO, about 171 million people around the world were diagnosed with diabetes in 2000, and the number is expected double by 2030.

For more information kindly visit :

Related Reports :

About Bharat Book Bureau :

Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry analysis, country reports, business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.


Contact us at :

Bharat Book Bureau

Tel: +91 22 27810772 / 27810773